cetylpyridinium chloride anhydrous has been researched along with Myotonic Dystrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baggiani, A; Emdin, M; Fierabracci, V; Fornaciari, I; Franzini, M; Gagliardi, G; Marchi, S; Miccoli, M; Paolicchi, A; Pompella, A; Ricci, G; Siciliano, G; Torracca, F; Volpi, L | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Myotonic Dystrophy
| Article | Year |
|---|---|
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease.
Topics: Adult; Case-Control Studies; Chemical Fractionation; Female; gamma-Glutamyltransferase; Health; Humans; Liver Diseases; Male; Middle Aged; Myotonic Dystrophy | 2010 |